litlas
ログインアカウント作成

Vikas P. Sukhatme

1984–2024 年に発表

127
論文数
36,733
被引用数
101
h 指数
126
i10 指数

被引用数

Vikas P. Sukhatme の年別被引用数1964 年: 被引用 1 件1971 年: 被引用 1 件1985 年: 被引用 7 件1986 年: 被引用 6 件1987 年: 被引用 5 件1988 年: 被引用 27 件1989 年: 被引用 54 件1990 年: 被引用 85 件1991 年: 被引用 137 件1992 年: 被引用 123 件1993 年: 被引用 152 件1994 年: 被引用 183 件1995 年: 被引用 227 件1996 年: 被引用 251 件1997 年: 被引用 203 件1998 年: 被引用 228 件1999 年: 被引用 300 件2000 年: 被引用 343 件2001 年: 被引用 353 件2002 年: 被引用 331 件2003 年: 被引用 316 件2004 年: 被引用 330 件2005 年: 被引用 330 件2006 年: 被引用 293 件2007 年: 被引用 377 件2008 年: 被引用 354 件2009 年: 被引用 335 件2010 年: 被引用 321 件2011 年: 被引用 297 件2012 年: 被引用 259 件2013 年: 被引用 306 件2014 年: 被引用 269 件2015 年: 被引用 249 件2016 年: 被引用 268 件2017 年: 被引用 292 件2018 年: 被引用 262 件2019 年: 被引用 852 件2020 年: 被引用 925 件2021 年: 被引用 876 件2022 年: 被引用 671 件2023 年: 被引用 464 件2024 年: 被引用 605 件2025 年: 被引用 269 件2026 年: 被引用 3 件1965〜1970 年は被引用が無いため表示していません1972〜1984 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,454 件、この内訳の 34.2%中国: 引用元論文 1,265 件、この内訳の 9.7%イギリス: 引用元論文 796 件、この内訳の 6.1%ドイツ: 引用元論文 661 件、この内訳の 5.1%カナダ: 引用元論文 489 件、この内訳の 3.8%日本: 引用元論文 462 件、この内訳の 3.6%イタリア: 引用元論文 422 件、この内訳の 3.2%フランス: 引用元論文 404 件、この内訳の 3.1%オーストラリア: 引用元論文 332 件、この内訳の 2.6%オランダ: 引用元論文 264 件、この内訳の 2%スペイン: 引用元論文 240 件、この内訳の 1.8%インド: 引用元論文 201 件、この内訳の 1.5%
0%34.2%その他 23.3%

機関

分野

  • Medicine42.4%
  • Biochemistry, Genetics and Molecular Biology41.5%
  • Immunology and Microbiology5.7%
  • Neuroscience3.6%
  • Computer Science1.7%
  • Engineering1.3%
  • その他3.8%

トピック

  • Pregnancy and preeclampsia studies6%
  • Cancer, Hypoxia, and Metabolism4.3%
  • Angiogenesis and VEGF in Cancer3.7%
  • Birth, Development, and Health2.7%
  • Reproductive System and Pregnancy2.5%
  • Renal and related cancers1.6%
  • その他79.2%

共著者

全論文

検索で開く
  1. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

    著者: Sharon E. Maynard, Jiangyong Min, Jaime R. Merchan, Kee-Hak Lim, Jianyi Li, Susanta Mondal, Towia A. Libermann, James P. Morgan, Frank W. Sellke, Isaac E. Stillman, Franklin H. Epstein, Vikas P. Sukhatme, S. Ananth Karumanchi - Journal of Clinical Investigation 2003 被引用: 3,967

  2. Tumor-Derived Lactate Modifies Antitumor Immune Response: Effect on Myeloid-Derived Suppressor Cells and NK Cells

    著者: Zaheed Husain, Yannu Huang, Pankaj Seth, Vikas P. Sukhatme - The Journal of Immunology 2013 被引用: 816

  3. Circulating Angiogenic Factors and the Risk of Preeclampsia

    著者: Richard J. Levine, Sharon E. Maynard, Cong Qian, Kee-Hak Lim, Lucinda J. England, Kai F. Yu, Enrique F. Schisterman, Ravi Thadhani, Benjamin Sachs, Franklin H. Epstein, Baha M. Sibai, Vikas P. Sukhatme, S. Ananth Karumanchi - New England Journal of Medicine 2004 被引用: 3,599

  4. Soluble endoglin contributes to the pathogenesis of preeclampsia

    著者: Shivalingappa Venkatesha, Mourad Toporsian, Chun Sing Lam, Jun‐ichi Hanai, Tadanori Mammoto, Yeon M. Kim, Yuval Bdolah, Kee-Hak Lim, Haitao Yuan, Towia A. Libermann, Isaac E. Stillman, Drucilla J. Roberts, Patrìcia A. D'Amore, Franklin H. Epstein, Frank W. Sellke, Roberto Romero, Vikas P. Sukhatme, Michelle Letarte, S. Ananth Karumanchi - Nature Medicine 2006 被引用: 1,843

  5. Targeting Lactate Dehydrogenase-A Inhibits Tumorigenesis and Tumor Progression in Mouse Models of Lung Cancer and Impacts Tumor-Initiating Cells

    著者: Han Xie, Jun‐ichi Hanai, Jian-Guo Ren, Lev M. Kats, Kerri Burgess, Parul Bhargava, Sabina Signoretti, Julia Billiard, Kevin J. Duffy, Aaron K. Grant, Xiaoen Wang, Pawel Lorkiewicz, Sabrina Schatzman, Michael Bousamra, Andrew N. Lane, Richard M. Higashi, Teresa W.‐M. Fan, Pier Paolo Pandolfi, Vikas P. Sukhatme, Pankaj Seth - Cell Metabolism 2014 被引用: 520

  6. Carbon Monoxide Expedites Metabolic Exhaustion to Inhibit Tumor Growth

    著者: Barbara Wegiel, David Gallo, Eva Csizmadia, Clair Harris, John D. Belcher, Gregory M. Vercellotti, Nuno Penacho, Pankaj Seth, Vikas P. Sukhatme, Asif Ahmed, Pier Paolo Pandolfi, Leszek Helczynski, Anders Bjartell, Jenny L. Persson, Leo E. Otterbein - Cancer Research 2013 被引用: 373

  7. Functional interactions of the cystine/glutamate antiporter, CD44v and MUC1-C oncoprotein in triple-negative breast cancer cells

    著者: Masanori Hasegawa, Hidekazu Takahashi, Hasan Rajabi, Maroof Alam, Yozo Suzuki, Yin Li, Ashujit Tagde, Takahiro Maeda, Masayuki Hiraki, Vikas P. Sukhatme, Donald Küfe - Oncotarget 2016 被引用: 199

  8. Tumor-derived lactate and myeloid-derived suppressor cells: Linking metabolism to cancer immunology

    著者: Zaheed Husain, Pankaj Seth, Vikas P. Sukhatme - OncoImmunology 2013 被引用: 151

  9. Excess Circulating Angiopoietin-2 May Contribute to Pulmonary Vascular Leak in Sepsis in Humans

    著者: Samir M. Parikh, Tadanori Mammoto, Aylit Schultz, Haitao Yuan, David C. Christiani, S. Ananth Karumanchi, Vikas P. Sukhatme - PLoS Medicine 2006 被引用: 533

  10. Resolvins suppress tumor growth and enhance cancer therapy

    著者: Megan L. Sulciner, Charles N. Serhan, Molly M. Gilligan, Dayna K. Mudge, Jaimie Chang, Allison Gartung, Kristen Lehner, Diane R. Bielenberg, Birgitta Schmidt, Jesmond Dalli, Emily R. Greene, Yael Gus‐Brautbar, Julia Piwowarski, Tadanori Mammoto, David Zurakowski, Mauro Perretti, Vikas P. Sukhatme, Arja Kaipainen, Mark W. Kieran, Sui Huang, Dipak Panigrahy - The Journal of Experimental Medicine 2017 被引用: 257

  11. Repurposing Drugs in Oncology (ReDO)—chloroquine and hydroxychloroquine as anti-cancer agents

    著者: Ciska Verbaanderd, Hannelore Maes, Marco B.E. Schaaf, Vikas P. Sukhatme, Pan Pantziarka, Vidula Sukhatme, Patrizia Agostinis, Gauthier Bouche - ecancermedicalscience 2017 被引用: 275

  12. Preoperative stimulation of resolution and inflammation blockade eradicates micrometastases

    著者: Dipak Panigrahy, Allison Gartung, Jun Yang, Haixia Yang, Molly M. Gilligan, Megan L. Sulciner, Swati S. Bhasin, Diane R. Bielenberg, Jaimie Chang, Birgitta Schmidt, Julia Piwowarski, Anna Fishbein, Dulce Soler-Ferran, Matthew A. Sparks, Steven J. Staffa, Vidula Sukhatme, Bruce D. Hammock, Mark W. Kieran, Sui Huang, Manoj Bhasin, Charles N. Serhan, Vikas P. Sukhatme - Journal of Clinical Investigation 2019 被引用: 137

  13. Drug repurposing in oncology—patient and health systems opportunities

    著者: Francesco Bertolini, Vikas P. Sukhatme, Gauthier Bouche - Nature Reviews Clinical Oncology 2015 被引用: 294

  14. Inhibition of lung cancer growth: ATP citrate lyase knockdown and statin treatment leads to dual blockade of mitogen‐activated protein Kinase (MAPK) and Phosphatidylinositol‐3‐kinase (PI3K)/AKT pathways

    著者: Jun‐ichi Hanai, Nathaniel C. Doro, Atsuo T. Sasaki, Susumu Kobayashi, Lewis C. Cantley, Pankaj Seth, Vikas P. Sukhatme - Journal of Cellular Physiology 2011 被引用: 164

  15. ReDO_DB: the repurposing drugs in oncology database

    著者: Pan Pantziarka, Ciska Verbaanderd, Vidula Sukhatme, Rica Capistrano, Sergio Crispino, Bishal Gyawali, Ilse Rooman, An M. T. Van Nuffel, Lydie Meheus, Vikas P. Sukhatme, Gauthier Bouche - ecancermedicalscience 2018 被引用: 133

  16. Fluvoxamine: A Review of Its Mechanism of Action and Its Role in COVID-19

    著者: Vikas P. Sukhatme, Vikas P. Sukhatme, Angela M. Reiersen, Sharat J. Vayttaden, Vidula V. Sukhatme, Vidula V. Sukhatme - Frontiers in Pharmacology 2021 被引用: 196

  17. Aspirin-triggered proresolving mediators stimulate resolution in cancer

    著者: Molly M. Gilligan, Allison Gartung, Megan L. Sulciner, Paul C. Norris, Vikas P. Sukhatme, Diane R. Bielenberg, Sui Huang, Mark W. Kieran, Charles N. Serhan, Dipak Panigrahy - National Academy of Sciences, Proceedings of the National Academy of Sciences 2019 被引用: 149

  18. Citrate Suppresses Tumor Growth in Multiple Models through Inhibition of Glycolysis, the Tricarboxylic Acid Cycle and the IGF-1R Pathway

    著者: Jian-Guo Ren, Pankaj Seth, Huihui Ye, Kun Guo, Jun‐ichi Hanai, Zaheed Husain, Vikas P. Sukhatme - Scientific Reports 2017 被引用: 132

  19. Taxane chemotherapy induces stromal injury that leads to breast cancer dormancy escape

    著者: Ramya Ganesan, Swati S. Bhasin, Mojtaba Bakhtiary, Upaasana Krishnan, Nagarjuna R. Cheemarla, Beena Thomas, Manoj Bhasin, Vikas P. Sukhatme - PLoS Biology 2023 被引用: 25

  20. Modeling precision treatment of breast cancer

    著者: Anneleen Daemen, Obi L. Griffith, Laura M. Heiser, Nicholas J. Wang, Oana M. Enache, Zachary Sanborn, François Pépin, Steffen Durinck, James E. Korkola, Malachi Griffith, Joe S. Hur, Nam Huh, Jongsuk Chung, Leslie Cope, Mary Jo Fackler, Christopher B. Umbricht, Saraswati Sukumar, Pankaj Seth, Vikas P. Sukhatme, Lakshmi R. Jakkula, Yiling Lu, Gordon B. Mills, Raymond J. Cho, Eric A. Collisson, Laura J. van’t Veer, Paul T. Spellman, Joe W. Gray - Genome biology 2013 被引用: 318

  21. Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents

    著者: Kazushige Hanaoka, Feng Qian, Alessandra Boletta, Anil K. Bhunia, Klaus Piontek, Leonidas Tsiokas, Vikas P. Sukhatme, William B. Guggino, Gregory G. Germino - Nature 2000 被引用: 819

  22. Canstatin, a Novel Matrix-derived Inhibitor of Angiogenesis and Tumor Growth

    著者: George D. Kamphaus, Pablo Colorado, David J. Panka, Helmut Hopfer, Ramani Ramchandran, Adriana de la Torre, Yohei Maeshima, James W. Mier, Vikas P. Sukhatme, Raghu Kalluri - Journal of Biological Chemistry 2000 被引用: 474

  23. Repurposing Drugs in Oncology (ReDO)—diclofenac as an anti-cancer agent

    著者: Pan Pantziarka, Vidula Sukhatme, Gauthier Bouche, Lydie Melhuis, Vikas P. Sukhatme - ecancermedicalscience 2016 被引用: 118

  24. Design and synthesis of emodin derivatives as novel inhibitors of ATP-citrate lyase

    著者: Steffi Koerner, Jun‐ichi Hanai, Sha Bai, Finith E. Jernigan, Miwa Oki, Chieko Komaba, Emi Shuto, Vikas P. Sukhatme, Lijun Sun - European Journal of Medicinal Chemistry 2016 被引用: 86